1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2.Hemodynamic parameters during 16 procedures involving intra-arterial vasospasm treatment in 12 patients
Pt/Procedure No. Total Verapamil (mg) HHH Therapy HR (bpm) MAP (mm Hg) ICP (mm Hg) Initial Nadir Initial Nadir Goal Initial Peak 1/1 30 No 102 57 108 86 17 17 1/2 20 No 85 79 104 96 4 4 2 10 Yesa 68 60 117 97 120–130 7 8 3 25 No 96 96 83 76 10 12 4 30 No 78 75 114 91 5 20 Yesa 125 100 85 71 120–130 6 20 Yesa 87 80 136 100 120–130 7/1 30 Noa 95 86 129 112 6 10 7/2 30 Yesa 94 91 130 130 145–155 8/1 30 No 73 64 77 64 8/2 20 Yesa 95 84 134 111 125–140 8/3 10 Yesa 125 94 117 103 135–145 9 10 No 85 68 85 81 10 20 No 131 106 114 112 16 20 11 20 No 65 65 103 98 7 8 12 30 No 90 86 105 95 15 15
a Refer to text for therapy changes during the procedure.